Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06802614 · ClinicalTrials.gov registry record · NA
Efficacy and Safety Assessment of Experimental Bleaching Agents
A NA study, sponsored by University of Oklahoma.
- Not yet
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT06802614: Clinical Trial NA study, sponsored by University of Oklahoma.
NCT06802614 is a NA study that has not yet begun recruiting, run by University of Oklahoma. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06802614, a NA study, has not yet begun recruiting, sponsored by University of Oklahoma.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
Tooth bleaching is widely used to treat the colors of teeth. This study compares the efficiency of two experimental bleaching gels, with and without nanoparticles, and with and without light activation versus two commercial bleaching products of low and high concentrations. The objective is to evaluate tooth color change, sensitivity, and patient satisfaction in patients with moderate yellowing of their teeth. Methods: This is a randomized controlled trial that will include 120 participants aged 18-65 years. Participants will be randomly assigned to one of 12 treatment groups: Gel A (with or without nanoparticles, with or without light), Gel B (with or without nanoparticles, with or without light), Whiteness HP 35% (with or without light) and Whiteness Automixx 6% (with or without light). The primary outcome is tooth color change, measured using a commercially-available equipment. Secondary outcomes will include tooth sensitivity and patient satisfaction. Randomization will be computer-generated. Results: The study is expected to show differences in color change between the experimental and commercial gels. Tooth sensitivity and patient satisfaction will be evaluated to determine the overall effectiveness and safety of the treatments. Conclusions: This trial will provide information into the whitening efficacy of two experimental gels compared to two widely used commercial products.
Primary Outcome
Delta E ; This outcome measure is dimensionless and will be extracted from L\*, a\* and b\* values.
Interventions
- DEVICE BLEACHING GEL A
- DEVICE 5% NF_TiO2
- DEVICE BLEACHING GEL B
- RADIATION VISIBLE LIGHT IRRADIATION
- DEVICE Whiteness HP 35%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What is known before NCT06802614 opens enrollment
NCT06802614 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 5 interventions - of which BLEACHING GEL A is the first listed.
NCT06802614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06802614 about?
NCT06802614 is a clinical study titled "Efficacy and Safety Assessment of Experimental Bleaching Agents". Tooth bleaching is widely used to treat the colors of teeth. This study compares the efficiency of two experimental bleaching gels, with and without nanoparticles, and with and without light activation versus two commercial bleaching products of low and high concentrations. The objective is to evalu...
What is the current status of trial NCT06802614?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2025-03-01. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT06802614?
The interventions under investigation include: BLEACHING GEL A (DEVICE), 5% NF_TiO2 (DEVICE), BLEACHING GEL B (DEVICE), VISIBLE LIGHT IRRADIATION (RADIATION), Whiteness HP 35% (DEVICE).
Who is sponsoring clinical trial NCT06802614?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06802614's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI